Skip to main navigation
Apexigen, Inc. Logo

Press Releases

Date Title View
January 24, 2023
Apexigen Announces Approximately $2.8 Million Private Placement Financing
January 19, 2023
Apexigen Announces New Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, at ASCO Gastrointestinal Cancers Symposium 2023
  • Investors Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Financial Information
    • SEC Filings
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact Us
Print Page
Email Alerts
RSS Feeds
Investor Contact
  • Home
  • About
  • Pipeline
  • Science
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Governance Documents
      • Committee Charters
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • Contact
  • Terms of Use
  • About
  • Pipeline
  • Science
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Governance Documents
      • Committee Charters
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • Contact
  • Apexigen, Inc. Logo
© 2022 Apexigen, Inc.All rights reserved
  • Terms of Use
Website Design: Hane Chow, Inc.